Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Neoplasms of the CNS

  Free Subscription


24.07.2017

1 Acta Neuropathol
1 BMC Cancer
1 Clin Cancer Res
4 Int J Radiat Oncol Biol Phys
5 J Clin Oncol
4 J Neurooncol
1 Oncogene
1 PLoS One
1 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neuropathol

  1. NEUMANN JE, Swartling FJ, Schuller U
    Medulloblastoma: experimental models and reality.
    Acta Neuropathol. 2017 Jul 19. doi: 10.1007/s00401-017-1753.
    PubMed     Text format     Abstract available


    BMC Cancer

  2. MIELE E, Po A, Begalli F, Antonucci L, et al
    beta-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells.
    BMC Cancer. 2017;17:488.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  3. OIZEL K, Chauvin C, Oliver L, Gratas C, et al
    Efficient mitochondrial glutamine targeting prevails over glioblastoma metabolic plasticity.
    Clin Cancer Res. 2017 Jul 18. pii: clincanres.3102.2016.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  4. BOUCHET A, Potez M, Coquery N, Rome C, et al
    Permeability of Brain Tumor Vessels Induced by Uniform or Spatially Microfractionated Synchrotron Radiation Therapies.
    Int J Radiat Oncol Biol Phys. 2017;98:1174-1182.
    PubMed     Text format     Abstract available

  5. SPERDUTO PW, Jiang W, Brown PD, Braunstein S, et al
    The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2017;98:1069-1077.
    PubMed     Text format     Abstract available

  6. WERNICKE AG, Hirschfeld CB, Smith AW, Taube S, et al
    Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.
    Int J Radiat Oncol Biol Phys. 2017;98:1059-1068.
    PubMed     Text format     Abstract available

  7. REDMOND KJ, Hales RK, Anderson-Keightly H, Zhou XC, et al
    Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:603-611.
    PubMed     Text format     Abstract available


    J Clin Oncol

  8. SOLOMON BJ, Cappuzzo F, Felip E, Blackhall FH, et al
    Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014.
    J Clin Oncol. 2016 Mar 28. pii: JCO635888.
    PubMed     Text format     Abstract available

  9. SCHMITZ N, Zeynalova S, Nickelsen M, Kansara R, et al
    CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.
    J Clin Oncol. 2016 Jul 5. pii: JCO656520.
    PubMed     Text format     Abstract available

  10. CRINO L, Ahn MJ, De Marinis F, Groen HJ, et al
    Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2.
    J Clin Oncol. 2016 Jul 18. pii: JCO655936.
    PubMed     Text format     Abstract available

  11. LASSALETTA A, Zapotocky M, Mistry M, Ramaswamy V, et al
    Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.
    J Clin Oncol. 2017 Jul 20:JCO2016718726. doi: 10.1200/JCO.2016.71.8726.
    PubMed     Text format     Abstract available

  12. GADGEEL SM, Shaw AT, Govindan R, Gandhi L, et al
    Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non-Small-Cell Lung Cancer.
    J Clin Oncol. 2016;34:4079-4085.
    PubMed     Text format     Abstract available


    J Neurooncol

  13. ZANELLO M, Roux A, Ursu R, Peeters S, et al
    Recurrent glioblastomas in the elderly after maximal first-line treatment: does preserved overall condition warrant a maximal second-line treatment?
    J Neurooncol. 2017 Jul 19. doi: 10.1007/s11060-017-2573.
    PubMed     Text format     Abstract available

  14. TIAN J, Luo Y, Xiang J, Tang J, et al
    Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.
    J Neurooncol. 2017 Jul 19. doi: 10.1007/s11060-017-2572.
    PubMed     Text format     Abstract available

  15. ZHANG C, de Smith AJ, Smirnov IV, Wiencke JK, et al
    Non-additive and epistatic effects of HLA polymorphisms contributing to risk of adult glioma.
    J Neurooncol. 2017 Jul 18. doi: 10.1007/s11060-017-2569.
    PubMed     Text format     Abstract available

  16. VIETHEER JM, Rieger J, Wagner M, Senft C, et al
    Serum concentrations of glial fibrillary acidic protein (GFAP) do not indicate tumor recurrence in patients with glioblastoma.
    J Neurooncol. 2017 Jul 17. doi: 10.1007/s11060-017-2565.
    PubMed     Text format     Abstract available


    Oncogene

  17. RODRIGUEZ-BLANCO J, Pednekar L, Penas C, Li B, et al
    Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    PLoS One

  18. MASCHIO M, Beghi E, Casazza MML, Colicchio G, et al
    Patterns of care of brain tumor-related epilepsy. A cohort study done in Italian Epilepsy Center.
    PLoS One. 2017;12:e0180470.
    PubMed     Text format     Abstract available


    Radiology

  19. SMITS M, van den Bent MJ
    Imaging Correlates of Adult Glioma Genotypes.
    Radiology. 2017;284:316-331.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: